What is the most recent earnings date for WST stock?
WEST PHARMACEUTICAL SERVICES (WST) last reported earnings on 2/12/2026.
WEST PHARMACEUTICAL SERVICES (WST) Earnings History & Surprises
NYSE:WST • US9553061055
Current stock price
250.64 USD
+5.5 (+2.24%)
At close:
250.64 USD
0 (0%)
After Hours:
WST Earnings overview
Past quarterly earnings results for WEST PHARMACEUTICAL SERVICES (WST), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 23, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $1.69
- Revenue Estimate
- 786.62M
Last Reported
Most Recent- Release Date
- Feb 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- $2.04
- EPS Surprise
- 10.24%
- Revenue Surprise
- 0.33%
Beat Rate
Last 8 Quarters 88%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 2.04 | 1.85 | 10.24% | 12.09% | 805M | 802.32M | 0.33% | 7.51% |
| Q3 2025 | 1.96 | 1.70 | 15.40% | 5.95% | 804.6M | 795.81M | 1.10% | 7.73% |
| Q2 2025 | 1.84 | 1.52 | 20.68% | 21.05% | 766.5M | 734.72M | 4.33% | 9.17% |
| Q1 2025 | 1.45 | 1.25 | 16.40% | -7.05% | 698M | 692.7M | 0.77% | 0.37% |
| Q4 2024 | 1.82 | 1.74 | 4.78% | -0.55% | 748.8M | 747.88M | 0.12% | 2.30% |
| Q3 2024 | 1.85 | 1.52 | 22.11% | -14.35% | 746.9M | 716.71M | 4.21% | -0.07% |
| Q2 2024 | 1.52 | 1.76 | -13.56% | -27.96% | 702.1M | 736.64M | -4.69% | -6.86% |
| Q1 2024 | 1.56 | 1.29 | 21.26% | -21.21% | 695.4M | 677.32M | 2.67% | -2.96% |
| Q4 2023 | 1.83 | 1.80 | 1.93% | 3.39% | 732M | 746.86M | -1.99% | 3.29% |
| Q3 2023 | 2.16 | 1.87 | 15.21% | 6.40% | 747.4M | 757.81M | -1.37% | 8.81% |
| Q2 2023 | 2.11 | 1.95 | 8.45% | -14.57% | 753.8M | 763.26M | -1.24% | -2.27% |
| Q1 2023 | 1.98 | 1.69 | 17.48% | -13.91% | 716.6M | 705.17M | 1.62% | -0.47% |
| Q4 2022 | 1.77 | 1.39 | 27.34% | -13.24% | 708.7M | 663.74M | 6.77% | -3.02% |
| Q3 2022 | 2.03 | 2.14 | -5.19% | -1.46% | 686.9M | 738.23M | -6.95% | -2.77% |
| Q2 2022 | 2.47 | 2.24 | 10.49% | 0.41% | 771.3M | 764.77M | 0.85% | 6.59% |
| Q1 2022 | 2.30 | 2.14 | 7.25% | 12.20% | 720M | 728.13M | -1.12% | 7.35% |
| Q4 2021 | 2.04 | 1.93 | 5.47% | 52.24% | 730.8M | 717.3M | 1.88% | 25.96% |
| Q3 2021 | 2.06 | 1.81 | 13.52% | 79.13% | 706.5M | 693.96M | 1.81% | 28.92% |
| Q2 2021 | 2.46 | 1.76 | 39.98% | 96.80% | 723.6M | 676.08M | 7.03% | 37.25% |
| Q1 2021 | 2.05 | 1.45 | 41.77% | 102.97% | 670.7M | 617.51M | 8.61% | 36.46% |
| Q4 2020 | 1.34 | 1.14 | 17.93% | - | 580.2M | 549.11M | 5.66% | - |
| Q3 2020 | 1.15 | 1.01 | 14.15% | - | 548M | 515.25M | 6.36% | - |
| Q2 2020 | 1.25 | 0.92 | 36.38% | - | 527.2M | 501.05M | 5.22% | - |
| Q1 2020 | 1.01 | 0.83 | 21.65% | - | 491.5M | 471.46M | 4.25% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
15.68%
Max EPS beat (4)
20.68%
Min EPS beat (4)
10.24%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
1.63%
Max Revenue beat (4)
4.33%
Min Revenue beat (4)
0.33%
Analysis
In the last 4 quarters, WST has consistently beaten EPS estimates in all releases
WST has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, WST has beaten the EPS estimates by 15.7% on average.
In the last 4 quarters, WST has beaten the revenue estimates by 1.6% on average.
Related analysis
WEST PHARMACEUTICAL SERVICES / WST Earnings FAQ
Did WST stock beat earnings estimates in the most recent quarter?
WEST PHARMACEUTICAL SERVICES (WST) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does WEST PHARMACEUTICAL SERVICES (WST) beat earnings estimates?
In the last 4 quarters, WEST PHARMACEUTICAL SERVICES (WST) has beaten EPS estimates in 4 out of 4 releases.